Evidence-Based Guidelines for Interpretation of the Hamilton Rating Scale for Depression

2007 ◽  
Vol 27 (5) ◽  
pp. 531-534 ◽  
Author(s):  
Toshi A. Furukawa ◽  
Tatsuo Akechi ◽  
Hideki Azuma ◽  
Toru Okuyama ◽  
Teruhiko Higuchi
2018 ◽  
Vol 28 (5) ◽  
pp. 544-562 ◽  
Author(s):  
P. L. de Zwart ◽  
B. F. Jeronimus ◽  
P. de Jonge

Aims.For the past quarter of a century, Frank et al.’s (1991) consensus-based definitions of major depressive disorder (MDD) episode, remission, recovery, relapse and recurrence have been the paramount driving forces for consistency in MDD research as well as in clinical practice. This study aims to review the evidence for the empirical validation of Frank et al.’s proposed concept definitions and to discuss evidence-based modifications.Methods.A literature search of Web of Science and PubMed from 1/1/1991 to 08/30/2017 identified all publications which referenced Frank et al.’s request for definition validation. Publications with data relevant for validation were included and checked for referencing other studies providing such data.Results.A total of 56 studies involving 39 315 subjects were included, mainly presenting data to validate the severity and duration thresholds for defining remission and recovery. Most studies indicated that the severity threshold for defining remission should decrease. Additionally, specific duration thresholds to separate remission from recovery did not add any predictive value to the notion that increased remission duration alleviates the risk of reoccurrence of depressive symptoms. Only limited data were available to validate the severity and duration criteria for defining a depressive episode.Conclusions.Remission can best be defined as a less symptomatic state than previously assumed (Hamilton Rating Scale for Depression, 17-item version (HAMD-17) ⩽4 instead of ⩽7), without applying a duration criterion. Duration thresholds to separate remission from recovery are not meaningful. The minimal duration of depressive symptoms to define a depressive episode should be longer than 2 weeks, although further studies are required to recommend an exact duration threshold. These results are relevant for researchers and clinicians aiming to use evidence-based depression outcomes.


Ners Muda ◽  
2021 ◽  
Vol 2 (3) ◽  
Author(s):  
Meliawati Putri Salsabila ◽  
Heryanto Adi Nugroho

Gagal jantung meningkatkan resiko kematian mendadak sehingga membutuhkan penanganan sesuai dengan tingkat keparahannya. Pada pasien penyakit kardiovaskuler lazim merasakan kecemasan dan stress. Kecemasan pada pasien dengan penyakit kardiovaskuler dapat dibantu salah satunya dengan tindakan non farmakologi. Pada studi kasus ini penanganan kecemasan pasien gagal jantung menggunakan intervensi terapi murottal al-qur’an. Tujuan umum studi kasus ini untuk menganalisa penurunan tingkat kecemasan pasien gagal jantung terhadap pemberian terapi murottal al-qur’an. Studi kasus ini menggunakan metode deskriptif dengan pendekatan proses keperawatan. Subjek studi kasus ini adalah pasien gagal jantung kongestif dan berjumlah 2 orang yang didapatkan secara purposive sampling. Studi kasus ini dilakukan di Ruang Ayyub 2 RS. Roemani Kota Semarang pada tanggal 13 Februari 2020 – 15 Februari 2020. Pengkajian kecemasan dan pengukuran tingkat kecemasan menggunakan kuisioner HARS (Hamilton Rating Scale Of Anxiety).  Prosedur pelaksanaan studi kasus ini dilakukan sesuai dengan evidence based nursing yaitu dilaksanakan dengan durasi 15-20 menit selama 3 hari. Hasil studi evaluasi menunjukkan bahwa sebelum dilakukan terapi murottal al-qur’an terjadi peningkatan kecemasan dan tanda-tanda vital serta gangguan tidur pada kedua pasien yang mengalami penurunan setelah dilakukan terapi murottal al-qur’an.Setelah dilakukan terapi murottal al-qur’an terdapat perbaikan pada tanda-tanda vital, penurunan tingkat kecemasan, dan penurunan gangguan tidur pada kedua pasien. Terapi murottal al-qur’an efektif dalam menurunkan tingkat kecemasan pada pasien dengan gagal jantung kongestif.


Crisis ◽  
2005 ◽  
Vol 26 (4) ◽  
pp. 170-180 ◽  
Author(s):  
Emma Preston ◽  
Lars Hansen

Abstract. In spite of a substantial number of suicides in patients with schizophrenia, this area of research has until very recently been the Cinderella of schizophrenia research. Both clinical and research practices have been hampered by a lack of assessment tolls specifically designed to measure suicidality in patients with schizophrenia. This has partly been because of uncertainty about what constitutes reliable risk factors for suicide in schizophrenia. A literature search following evidence-based guidelines was carried out. A number of relevant articles were found, which were then critically reviewed. The majority of rating scales used for patients with schizophrenia were actually based - at least partly - on patients with other diagnoses than schizophrenia (affective conditions, schizoaffective disorder). This procedure could result in misleading conclusions as a result of the heterogeneity of the different mental illnesses. We conclude that, at present, only one rating scale measuring suicidality specifically designed for patients with schizophrenia (the InterSePT-scale) is based on both sound methodology and has clinical relevance. Suicide in patients with schizophrenia remains a pressing problem in the treatment of this high-risk group.


2019 ◽  
Author(s):  
Pablo Rodrigo Guzman Cortez ◽  
Matias Marzocchi ◽  
Neus Freixa Fontanals ◽  
Mercedes Balcells-Olivero

BACKGROUND Computerized mental health interventions have shown evidence of their potential benefit for mental health outcomes in young users. All of the studied interventions available in the review and scientific literature can be classified as "serious games". Serious games are computerized interventions designed from the start with the objective of improving specific desired health outcomes. Moreover, there are reports of users experiencing subjective benefits in mental health after playing specific commercial games. These were games not intentionally made with a therapeutic objective in the design process. An example is the videogame "Journey", first released for the Playstation 3 console in 2012 which won "Game of the Year" in the 2013 D.I.C.E awards. The creator of the game describes the game as a short, 2-3-hour narrative experience in which the player goes through the "Hero's Journey" following a classic 3-part structure. There were more than 100 testimonials from players describing how the game helped them cope with psychological or personal issues. Some of them explicitly described recovering from depressive episodes through playing the game. OBJECTIVE To conduct a pilot test of the efficacy of the videogame Journey in reducing depressive symptoms in an acute impatient setting METHODS Depressive symptomatology was measured before and after the intervention using the Hamilton Rating Scale for Depression (HRSD) The intervention was conducted in an isolated room using a Playstation 3 console with the videogame "Journey" developed by Thatgamecompany. No internet access was allowed. The game was played over the course of 4 30-45 min sessions in a two week period. RESULTS The initial score in the Hamilton Rating Scale for Depression (HRSD) was 30, indicating a very severe depression. After the intervention the HRSD score was 10, showing a mild depression. CONCLUSIONS The Videogame Journey, a commercial game first available for the Playstation 3 console in 2012, was not created as a serious game with potential health benefits. Our pilot test is the first case report of a commercial game showing a potential effect in reducing depressive symptoms, which is consistent with the previous informal reports of users online.


2021 ◽  
pp. 263183182110311
Author(s):  
Adarsh Tripathi ◽  
Dhirendra Kumar ◽  
Sujita Kumar Kar ◽  
PK Dalal ◽  
Anil Nischal

Background: Erectile dysfunction (ED) is one of the most common psychosexual disorders in clinical practice, and it results in significant distress, interpersonal impairments, poor quality of life, and marital disharmony. However, there is limited research on ED in India. Therefore, this study aimed to assess the sociodemographic and clinical profile of patients presenting with ED. Method: Cross-sectional evaluation of patients with ED presenting to the psychosexual outpatient department (OPD) of psychiatry department in a tertiary care hospital was done on structured clinical pro forma, Mini-International Neuropsychiatric Interview, International Index of Erectile Function-5, Arizona Sexual Experience, Hamilton rating scale for depression, and Hamilton rating scale for anxiety. Results: The sample included 102 patients. The mean age was 33.38 years. The majority of the patients were married (81.4%), Hindu (82.4%), residing in a rural area (60.8%), and belonging to a nuclear family (62.7%). The majority of the patients had a moderate level of ED (50%) followed by mild-to-moderate ED (26.5%) and severe ED (23.5%). Premature ejaculation (46.1%) and depression (28.4%) were the most common sexual and psychiatric comorbidities. Obesity was common (62.7%), and only a minority had other metabolic dysfunction, namely dyslipidemia (7.8%), diabetes (5.9%), and hypertension (4.9%). Tobacco dependence and alcohol dependence were present in 37.3% and 6.9% cases, respectively. Conclusion: Young adults with moderate-to-severe ED were present for treatment at a tertiary center. Comorbidities of other sexual disorders, psychiatric disorders, and substance use are commonly encountered in such patients. Promotion of early help-seeking should be encouraged. Clinicians should thoroughly assess even the young patients for other sexual, psychiatric, and medical comorbidities.


Sign in / Sign up

Export Citation Format

Share Document